Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

OBJECTIVE: Hydroxychloroquine (HCQ) is a mainstay of therapy in the treatment of SLE. The effect of HCQ on platelets and vascular health is uncertain. We investigated the relationship between HCQ use and dose with platelet activity, platelet transcriptomics and vascular health in patients with SLE....

Descripción completa

Detalles Bibliográficos
Autores principales: Cornwell, MacIntosh Grant, Luttrell-Williams, Elliot S, Golpanian, Michael, El Bannoudi, Hanane, Myndzar, Khrystyna, Izmirly, Peter, Belmont, H Michael, Katz, Stuart, Smilowitz, Nathaniel R, Engel, Alexis, Clancy, Robert, Ruggles, Kelly, Buyon, Jill P, Berger, Jeffrey S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978255/
https://www.ncbi.nlm.nih.gov/pubmed/33737451
http://dx.doi.org/10.1136/lupus-2021-000475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978255/
https://www.ncbi.nlm.nih.gov/pubmed/33737451
http://dx.doi.org/10.1136/lupus-2021-000475

Ejemplares similares